BSX vs SLGN · P/E 20, rev $10.65B vs P/E 14, rev $3.20B
Boston Scientific Corp (BSX) versus Silgan Holdings Inc (SLGN) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Silgan Holdings Inc (SLGN) is a packaging & containers company listed on US.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported SLGN revenue for 2026-06-30 was $3.20B. Net income was $138.8M. SLGN currently screens at market cap $3.83B and trailing P/E 13.6.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. SLGN currently screens at market cap $3.83B and trailing P/E 13.6.
Not investment advice. Open the BSX and SLGN stock pages for the full models.
Not investment advice.